Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00438386 · ClinicalTrials.gov registry record · Phase 4
Aripiprazole for the Treatment of Refractory Anxiety
A Phase 4 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
NCT00438386: Completed Phase 4 study, sponsored by Massachusetts General Hospital.
NCT00438386 is a Phase 4 study that has completed, run by Massachusetts General Hospital. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00438386, a Phase 4 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
The purpose of this study is to determine whether aripiprazole is effective in the treatment of refractory panic and generalized anxiety disorder.
Interventions
- DRUG Aripiprazole
Trial Details
| Field | Value |
|---|---|
| Start Date | 2005-04 |
| Est. Completion | 2007-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00438386
The ClinicalTrials.gov registry entry for NCT00438386 describes a study currently listed as completed, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Aripiprazole is the first listed.
NCT00438386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00438386 about?
NCT00438386 is a clinical study titled "Aripiprazole for the Treatment of Refractory Anxiety". The purpose of this study is to determine whether aripiprazole is effective in the treatment of refractory panic and generalized anxiety disorder.
What is the current status of trial NCT00438386?
This trial is currently completed. It is a Phase 4 study. The study started on 2005-04. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00438386?
The interventions under investigation include: Aripiprazole (DRUG).
Who is sponsoring clinical trial NCT00438386?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.